This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;172(5):1194-5.

doi: 10.1111/bjd.13766.

Oral tofacitinib for psoriasis: what happens with interrupted treatment?

H Alinia¹, S R Feldman^{2

3

4}

Affiliations

Affiliations

¹ Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.. haliniamd@gmail.com.
² Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.
³ Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.
⁴ Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.

PMID: 25963217
DOI: 10.1111/bjd.13766

Comment

Oral tofacitinib for psoriasis: what happens with interrupted treatment?

H Alinia et al. Br J Dermatol. 2015 May.

. 2015 May;172(5):1194-5.

doi: 10.1111/bjd.13766.

Authors

H Alinia¹, S R Feldman^{2

3

4}

Affiliations

¹ Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.. haliniamd@gmail.com.
² Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.
³ Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.
⁴ Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, 27104, U.S.A.

PMID: 25963217
DOI: 10.1111/bjd.13766

No abstract available

PubMed Disclaimer

Comment on

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.
Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H, Gupta P, Mallbris L, Wolk R. Bissonnette R, et al. Br J Dermatol. 2015;172(5):1395-406. doi: 10.1111/bjd.13551. Epub 2015 Apr 2. Br J Dermatol. 2015. PMID: 25418186 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information